Peptide Therapeutics Market Size To Cross USD 76.83 Bn By 2032

The global peptide therapeutics market size accounted for US$ 43.11 Bn in 2022 and is projected to reach around USD 76.83 Bn by 2032, growing at a CAGR of 5.94% from 2023 to 2032.

Report Summary

The global peptide therapeutics market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the peptide therapeutics market across the globe.

A comprehensive estimate on the peptide therapeutics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of peptide therapeutics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2548

Peptide Therapeutics Market Report Scope 

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized peptide therapeutics market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Uninterruptible Power Supply (UPS) Market Size Analysis 2023 To 2032

Peptide Therapeutics Market Players

The report includes the profiles of key peptide therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

• Eli Lilly & Company
• Amgen Inc.
• Pfizer, Inc.
• Ever Neuro Pharma GmbH
• Bausch Health
• Abbvie

Market Segmentation

By Application

• Gastrointestinal Disorder
• Metabolic Disorder
• Neurological Disorder
• Cancer
• Others

By Type

• Generic
• Innovative

By Route of Administration

• Oral
• Parenteral
• Pulmonary
• Mucosal
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Drug Stores

By Synthesis Technology

• Solid Phase peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
• In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Peptide Therapeutics Market 

5.1. COVID-19 Landscape: Peptide Therapeutics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Peptide Therapeutics Market, By Application

8.1. Peptide Therapeutics Market, by Application, 2023-2032

8.1.1. Gastrointestinal Disorder

8.1.1.1. Market Revenue and Forecast (2023-2032)

8.1.2. Metabolic Disorder

8.1.2.1. Market Revenue and Forecast (2023-2032)

8.1.3. Neurological Disorder

8.1.3.1. Market Revenue and Forecast (2023-2032)

8.1.4. Cancer

8.1.4.1. Market Revenue and Forecast (2023-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 9. Global Peptide Therapeutics Market, By Type

9.1. Peptide Therapeutics Market, by Type, 2023-2032

9.1.1. Generic

9.1.1.1. Market Revenue and Forecast (2023-2032)

9.1.2. Innovative

9.1.2.1. Market Revenue and Forecast (2023-2032)

Chapter 10. Global Peptide Therapeutics Market, By Route of Administration 

10.1. Peptide Therapeutics Market, by Route of Administration, 2023-2032

10.1.1. Oral

10.1.1.1. Market Revenue and Forecast (2023-2032)

10.1.2. Parenteral

10.1.2.1. Market Revenue and Forecast (2023-2032)

10.1.3. Pulmonary

10.1.3.1. Market Revenue and Forecast (2023-2032)

10.1.4. Mucosal

10.1.4.1. Market Revenue and Forecast (2023-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2023-2032)

Chapter 11. Global Peptide Therapeutics Market, By Distribution Channel

11.1. Peptide Therapeutics Market, by Distribution Channel, 2023-2032

11.1.1. Hospital Pharmacies

11.1.1.1. Market Revenue and Forecast (2023-2032)

11.1.2. Retail Pharmacies

11.1.2.1. Market Revenue and Forecast (2023-2032)

11.1.3. Online Drug Stores

11.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 12. Global Peptide Therapeutics Market, By Synthesis Technology

12.1. Peptide Therapeutics Market, by Synthesis Technology, 2023-2032

12.1.1. Solid Phase peptide Synthesis (SPPS)

12.1.1.1. Market Revenue and Forecast (2023-2032)

12.1.2. Liquid Phase Peptide Synthesis (LPPS)

12.1.2.1. Market Revenue and Forecast (2023-2032)

12.1.3. Hybrid Technology

12.1.3.1. Market Revenue and Forecast (2023-2032)

Chapter 13. Global Peptide Therapeutics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Application (2023-2032)

13.1.2. Market Revenue and Forecast, by Type (2023-2032)

13.1.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.1.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.1.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Application (2023-2032)

13.1.6.2. Market Revenue and Forecast, by Type (2023-2032)

13.1.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.1.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.1.6.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Application (2023-2032)

13.1.7.2. Market Revenue and Forecast, by Type (2023-2032)

13.1.7.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.1.7.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.1.7.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Application (2023-2032)

13.2.2. Market Revenue and Forecast, by Type (2023-2032)

13.2.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.2.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.2.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Application (2023-2032)

13.2.6.2. Market Revenue and Forecast, by Type (2023-2032)

13.2.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.2.7. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.2.8. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Application (2023-2032)

13.2.9.2. Market Revenue and Forecast, by Type (2023-2032)

13.2.9.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.2.10. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.2.11. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Application (2023-2032)

13.2.12.2. Market Revenue and Forecast, by Type (2023-2032)

13.2.12.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.2.12.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.2.13. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Application (2023-2032)

13.2.14.2. Market Revenue and Forecast, by Type (2023-2032)

13.2.14.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.2.14.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.2.15. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Application (2023-2032)

13.3.2. Market Revenue and Forecast, by Type (2023-2032)

13.3.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.3.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.3.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Application (2023-2032)

13.3.6.2. Market Revenue and Forecast, by Type (2023-2032)

13.3.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.3.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.3.7. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Application (2023-2032)

13.3.8.2. Market Revenue and Forecast, by Type (2023-2032)

13.3.8.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.3.8.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.3.9. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Application (2023-2032)

13.3.10.2. Market Revenue and Forecast, by Type (2023-2032)

13.3.10.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.3.10.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.3.10.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Application (2023-2032)

13.3.11.2. Market Revenue and Forecast, by Type (2023-2032)

13.3.11.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.3.11.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.3.11.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Application (2023-2032)

13.4.2. Market Revenue and Forecast, by Type (2023-2032)

13.4.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.4.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.4.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Application (2023-2032)

13.4.6.2. Market Revenue and Forecast, by Type (2023-2032)

13.4.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.4.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.4.7. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Application (2023-2032)

13.4.8.2. Market Revenue and Forecast, by Type (2023-2032)

13.4.8.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.4.8.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.4.9. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Application (2023-2032)

13.4.10.2. Market Revenue and Forecast, by Type (2023-2032)

13.4.10.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.4.10.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.4.10.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Application (2023-2032)

13.4.11.2. Market Revenue and Forecast, by Type (2023-2032)

13.4.11.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.4.11.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.4.11.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Application (2023-2032)

13.5.2. Market Revenue and Forecast, by Type (2023-2032)

13.5.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.5.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.5.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Application (2023-2032)

13.5.6.2. Market Revenue and Forecast, by Type (2023-2032)

13.5.6.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.5.6.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.5.7. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Application (2023-2032)

13.5.8.2. Market Revenue and Forecast, by Type (2023-2032)

13.5.8.3. Market Revenue and Forecast, by Route of Administration (2023-2032)

13.5.8.4. Market Revenue and Forecast, by Distribution Channel (2023-2032)

13.5.8.5. Market Revenue and Forecast, by Synthesis Technology (2023-2032)

Chapter 14. Company Profiles

14.1. Eli Lilly & Company

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Amgen Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Pfizer, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ever Neuro Pharma GmbH

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bausch Health

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Abbvie

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com